They seem to received a complete response letter from the fda and according to their press release they do not seem to have a lot of work to do to, to respond to the letter and get approved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.